L

Lepu Medical Technology Beijing Co Ltd
SZSE:300003

Watchlist Manager
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Watchlist
Price: 11.68 CNY -0.93% Market Closed
Market Cap: 22B CNY
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one Lepu Medical Technology Beijing Co Ltd stock under the Base Case scenario is 16.11 CNY. Compared to the current market price of 11.68 CNY, Lepu Medical Technology Beijing Co Ltd is Undervalued by 28%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
16.11 CNY
Undervaluation 28%
Relative Value
Price
L
Worst Case
Base Case
Best Case

Valuation Multiples

3.4
P/S
P/S
Price to Sales
3.4
vs History
79
vs Industry
35
Median 3Y
3.5
Median 5Y
4
Industry
2.2
Forward
3.4
More Details
31.1
P/E
P/E
Price to Earnings
31.1
vs History
17
vs Industry
18
Median 3Y
22.9
Median 5Y
24.5
Industry
22.5
Forward
23.9
More Details
27.1
P/OCF
P/OCF
Price to OCF
27.1
vs History
20
vs Industry
13
Median 3Y
20
Median 5Y
20.4
Industry
13.9
More Details
19.6
P/FCFE
P/FCFE
Price to FCFE
19.6
vs History
88
vs Industry
23
Median 3Y
37
Median 5Y
35.9
Industry
19.7
More Details
1.4
P/B
P/B
Price to Book Value
1.4
vs History
92
vs Industry
54
Median 3Y
2
Median 5Y
2.8
Industry
2.1
More Details
3.6
EV/S
EV/S
Enterprise Value to Sales
3.6
vs History
71
vs Industry
31
Median 3Y
3.7
Median 5Y
3.9
Industry
2.3
Forward
3.7
More Details
5.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.9
vs History
71
vs Industry
38
Median 3Y
6
Median 5Y
6.3
Industry
4.9
More Details
23.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
23.6
vs History
25
vs Industry
14
Median 3Y
17.2
Median 5Y
18.5
Industry
11.9
Forward
12.7
More Details
23.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
23.6
vs History
25
vs Industry
19
Median 3Y
17.2
Median 5Y
18.5
Industry
16.4
Forward
19.1
More Details
28.9
EV/OCF
EV/OCF
Enterprise Value to OCF
28.9
vs History
17
vs Industry
13
Median 3Y
19.6
Median 5Y
20.5
Industry
13.7
More Details
147.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
147.2
vs History
9
vs Industry
3
Median 3Y
46.8
Median 5Y
34.8
Industry
17.2
More Details
1.1
EV/IC
EV/IC
Enterprise Value to IC
1.1
vs History
92
vs Industry
54
Median 3Y
1.7
Median 5Y
2.3
Industry
1.8
More Details

Multiples Across Competitors

Competitors Multiples
Lepu Medical Technology Beijing Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
22B CNY 3.4 31.1 23.6 23.6
US
Abbott Laboratories
NYSE:ABT
226.5B USD 5.4 16.9 22.6 33.1
US
Intuitive Surgical Inc
NASDAQ:ISRG
175.2B USD 21 75.4 58.4 70.8
US
Boston Scientific Corp
NYSE:BSX
146.4B USD 8.7 79 36.1 51
US
Stryker Corp
NYSE:SYK
139B USD 6.2 46.4 24.1 29.1
IE
Medtronic PLC
NYSE:MDT
112.5B USD 3.4 26.4 14.1 19.9
US
Becton Dickinson and Co
NYSE:BDX
65.8B USD 3.2 37.7 15.7 28.3
DE
Siemens Healthineers AG
XETRA:SHL
57.1B EUR 2.5 28.8 16.4 23.4
US
Edwards Lifesciences Corp
NYSE:EW
41.8B USD 7.7 10 23.5 25.9
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
288.7B CNY 7.8 23.3 20.4 20.4
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.6B USD 1.9 18.4 12.9 15.7

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 242,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.